Mesenbio
About:
Mesenbio is a preclinical biopharmaceutical business based at the University of York.
Website: https://www.mesenbio.net
Top Investors: Innovate UK, DSW Ventures, NG Bio
Description:
Mesenbio is a preclinical biopharmaceutical business based at the University of York. Its Cell Line Extracellular Vesicle Release (CLEVR) technique allows for a more diverse treatment pipeline by overcoming the most common hurdle in extracellular vesicle therapy.
Total Funding Amount:
1.4M GBP
Headquarters Location:
Newyork, Argyll and Bute, United Kingdom
Founded Date:
2021-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-01-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai